Insider · CIK 0001744046
Daniel Karp
Files at OGN (Organon & Co.). First filing May 7, 2025, latest May 7, 2025.
Daniel Karp files SEC Form 4 as officer at OGN (Organon & Co.). Since May 7, 2025, Daniel Karp has reported 1 open-market buy worth $29k and 0 open-market sells worth $0, the latest filed on May 7, 2025.
A track record needs three past buys with six months of prices behind them; Daniel Karp has 0, so none is measured yet.
The newest scored trade: bought $29k of OGN on May 6, 2025, filed May 7, 2025, scored 56 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
OGN: Organon & Co.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 56Moderate | Organon & Co. | $29k 3,500 shares | +8% | +5% from low-55% from high |
Transactions
Every row this insider has filed, 25 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | OGN Organon & Co. | MOption exercise Common Stock | +11,338 | $0.00 | $0 | 68,492 | Apr 2, 2026 |
| Mar 31, 2026 | OGN Organon & Co. | FTax withholding Common Stock | -3,554 | $5.70 | $20k | 64,938 | Apr 2, 2026 |
| Mar 31, 2026 | OGN Organon & Co. | MOption exercise Common Stock | +6,715 | $0.00 | $0 | 71,653 | Apr 2, 2026 |
| Mar 31, 2026 | OGN Organon & Co. | FTax withholding Common Stock | -2,105 | $5.70 | $12k | 69,548 | Apr 2, 2026 |
| Mar 31, 2026 | OGN Organon & Co. | AGrant or award Restricted Stock Unitsderivative | +100,166 | $0.00 | $0 | 100,166 | Apr 2, 2026 |
| Mar 31, 2026 | OGN Organon & Co. | MOption exercise Restricted Stock Unitsderivative | -11,338 | $0.00 | $0 | 0 | Apr 2, 2026 |
| Mar 31, 2026 | OGN Organon & Co. | MOption exercise Restricted Stock Unitsderivative | -6,715 | $0.00 | $0 | 13,432 | Apr 2, 2026 |
| Mar 29, 2026 | OGN Organon & Co. | MOption exercise Common Stock | +14,184 | $0.00 | $0 | 60,853 | Mar 31, 2026 |
| Mar 29, 2026 | OGN Organon & Co. | FTax withholding Common Stock | -4,446 | $5.84 | $26k | 57,154 | Mar 31, 2026 |
| Mar 29, 2026 | OGN Organon & Co. | MOption exercise Restricted Stock Unitsderivative | -14,184 | $0.00 | $0 | 14,185 | Mar 31, 2026 |
| May 6, 2025 | OGN Organon & Co. | POpen-market purchase Common Stock | +3,500 | $8.24 | $29k | 46,669 | May 7, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | MOption exercise Common Stock | +14,184 | $0.00 | $0 | 33,546 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | FTax withholding Common Stock | -4,446 | $14.51 | $65k | 29,100 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | MOption exercise Common Stock | +11,338 | $0.00 | $0 | 40,438 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | FTax withholding Common Stock | -3,554 | $14.51 | $52k | 36,884 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | MOption exercise Common Stock | +4,861 | $0.00 | $0 | 41,745 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | FTax withholding Common Stock | -1,524 | $14.51 | $22k | 40,221 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | MOption exercise Common Stock | +4,294 | $0.00 | $0 | 44,515 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | FTax withholding Common Stock | -1,346 | $14.51 | $20k | 43,169 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | AGrant or award Stock Option (right to buy)derivative | +99,009 | $0.00 | $0 | 99,009 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | AGrant or award Restricted Stock Unitsderivative | +20,147 | $0.00 | $0 | 20,147 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | MOption exercise Restricted Stock Unitsderivative | -14,184 | $0.00 | $0 | 28,369 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | MOption exercise Restricted Stock Unitsderivative | -11,338 | $0.00 | $0 | 11,338 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | MOption exercise Restricted Stock Unitsderivative | -4,861 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | MOption exercise Restricted Stock Unitsderivative | -4,294 | $0.00 | $0 | 0 | Apr 2, 2025 |
Questions about Daniel Karp
Answered from the filings on this page, as of the latest one.
Is Daniel Karp buying or selling?
Not in the last 12 months. Daniel Karp's latest open-market trade on SEC Form 4 was bought $29k of OGN on May 6, 2025.
How did Daniel Karp's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Daniel Karp has 0.
Where does Daniel Karp file Form 4?
Daniel Karp has filed Form 4 at OGN (Organon & Co.) as Executive VP, Corp. Dev.. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.